# Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma

> **NCT04225039** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Pennsylvania** · enrollment: 39 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **DRUG:** INCMGA00012
- **DRUG:** INCAGN01876
- **DRUG:** SRS
- **PROCEDURE:** Brain surgery

## Key facts

- **NCT ID:** NCT04225039
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-06-23
- **Primary completion:** 2022-09-08
- **Final completion:** 2029-04-30
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2025-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04225039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04225039, "Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT04225039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*